Catheter Precision (VTAK) announced that its previously announced 1-for-19 reverse stock split of its common stock became effective at 12:01 A.M. Eastern Time, on August 15, 2025. The Company’s common stock will continue to be traded on the NYSE American under the symbol “VTAK” and will begin trading on a split-adjusted basis when the market opens on August 15, 2025. The new CUSIP number for the Company’s common stock following the reverse stock split will be 74933X708.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision announces first LockeT cases completed in Germany
- Catheter Precision reports Q2 revenue $212,000 vs. $93,000 last year
- Upcoming Stock Splits This Week (August 11 to August 15) – Stay Invested
- Catheter Precision: Heart Hospital completes 200 ablation procedures with VIVO
- Catheter Precision Approves Reverse Stock Split Plan